Foamix Pharmaceuticals - 48 Year Dividend History | FOMX

Historical dividend payout and yield for Foamix Pharmaceuticals (FOMX) since 1971. The current TTM dividend payout for Foamix Pharmaceuticals (FOMX) as of November 13, 2019 is $0.00. The current dividend yield for Foamix Pharmaceuticals as of November 13, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.208B $0.004B
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company's lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.
Stock Name Country Market Cap PE Ratio